0% READ
FULL TEXT
INTRODUCTION
Plants have played a significant role in the treatment of various diseases for centuries. In fact, more than 90% of prescribed medicines have their origins in plants. However, the overuse of antibiotics has led to a surge in side effects and the emergence of antibiotic-resistant bacterial strains (Salam et al., 2023). To address this growing concern, researchers have turned to traditional herbal remedies as a potential source for the development of new chemotherapy drugs. These herbal remedies offer a fascinating and largely unexplored avenue for combating resistance and reducing the toxicity associated with commercially available antibiotics (Li et al., 2024). Studies have shown that extracts derived from medicinal plants possess potent antimicrobial properties, making them effective against pathogenic bacteria that affect humans. Furthermore, these extracts exhibit minimal adverse effects on the body. Numerous plants have been extensively investigated for their antimicrobial and antioxidant activities, as well as their potential toxicity. By harnessing the therapeutic potential of these plants, researchers aim to develop safer and more effective treatments for infectious diseases (Saravanan et al., 2017; Makwana et al., 2015; Hidera et al., 2024; Antonelo et al., 2021).
Acacia species, a fascinating medicinal source, possesses a multitude of therapeutic properties. The bark of Acacia chundra (AC) plant exhibits remarkable antioxidant, astringent, anti-inflammatory, anti-bacterial, and antifungal characteristics. Its extract is commonly employed in the treatment of various ailments, including sore throats, diarrhea, high blood pressure, dysentery, colitis, gastric problems, bronchial asthma, cough, and leprosy. Furthermore, it serves as an effective mouthwash for oral and dental infections, gum issues, and sore throats. The heartwood of AC yields a concentrated aqueous extract known as cutch, which displays astringent, cooling, and digestive properties. This extract finds utility in addressing coughs, ulcers, boils, and skin eruptions (Seigler et al., 2003). Additionally, the decoction of the plant's bark is administered internally for the management of leprosy. It is worth noting that Acacia spp. produces gum exudates, commonly referred to as gum Arabic or gum Acacia, which are extensively utilized in the food industry as emulsifiers, adhesives, stabilizers, and even in cases of chronic renal failure (Ali et al., 2009).
Phytochemicals, which possess antimicrobial and antioxidant properties, hold immense potential in suppressing both plant and human diseases. An antioxidant is a molecule that donates electrons or inhibits reduction reactions. These compounds, characterized by their small molecular weights, can effectively neutralize free radicals and reactive molecules, thereby preventing degenerative diseases. In addition to antibacterial derived from natural sources like plants, spices, and microorganisms, recent discoveries have unveiled a plethora of antibacterial agents from these natural ingredients (Chinedum et al., 2016). Notably, AC has been found to contain a significant amount of antioxidant components and antimicrobial molecules, which could aid in the prevention of various diseases. Recently, there has been a growing interest in studying and investigating medicinal plants to validate their activities and develop safe alternatives to synthetic drugs. Medicinal plants offer low-cost production processes and pose fewer environmental hazards, side effects, and toxicities compared to synthetic drugs (Tomayo et al., 2024). The primary objective of this study is to conduct a comprehensive assessment of the pharmacognostic screening, phytochemical analysis, antimicrobial activity, and antioxidant potential of the extract derived from AC leaves, bark and flowers collected from Maharashtra, India. By delving into these aspects, we aim to gain deeper insight into the medicinal properties and therapeutic potential of this plant species (Antonelo et al., 2023).
The results of the study revealed that the ethanol extract obtained from AC leaves, bark and flowers exhibited significant antibacterial activity against human pathogenic bacteria. Additionally, the extract demonstrated potent antioxidant activity, suggesting its potential in preventing degenerative diseases. The pharmacognostic screening and phytochemical analysis unveiled the presence of various bioactive compounds, including flavonoids, alkaloids, and phenolic compounds. These compounds are renowned for their antimicrobial and antioxidant properties, making them promising candidates for combating both plant and human diseases. The findings imply that AC holds promise as a valuable resource for the development of novel chemotherapy drugs, addressing the challenges associated with resistance and toxicity observed in current commercial antibiotics. Furthermore, the low-cost production processes, minimal environmental hazards, and reduced side effects and toxicity of medicinal plants position them as safe alternatives to synthetic drugs.
MATERIALS AND METHODS
Collection and authentication of plant samples
In September 2023, fresh leaves, bark, and flowers of Acacia chundra (AC) were collected from the Swami Ramanand Teerth Marathwada University campus, Nanded, Maharashtra, India. The plant specimens were authenticated by a taxonomist, and voucher specimens were deposited in the Herbarium, Department of Botany, School of Life Sciences, Swami Ramanand Teerth Marathwada University). The plant materials (leaves, bark and flowers) were meticulously washed with running tap water, followed by sterilized distilled water, to remove contaminants. The samples were then shade-dried at 25±2ºC to preserve bioactive compounds, and the dried materials were finely powdered using a sterilized pestle and mortar. The powdered samples were stored in airtight containers at 4ºC until further use.
Preparation of plant extract
The powdered plant samples (100 g/500 mL) were extracted successively with Solvents (water, chloroform and ether) using Soxhlet apparatus at 55-85ºC for 8-10 hr in order to extract the polar and non-polar compound. For each solvent extraction, the powdered pack material was air dried and then used. The solvents of the respective extracts were stored at 4ºC for further use. To analyze in vitro antimicrobial and antioxidant activity of plant extract dissolve the dried extracts in dimethyl sulfoxide and made the solution of 10 mg/10 mL (Hidera et al., 2024).
Material, Chemicals and reagents
To evaluate the antimicrobial, antioxidant, and cytotoxic potential of Acacia chundra extracts, the following materials and reagents were used. Dragendorff’s reagent, FeCl3, glacial acetic acid, Terpenoids, HCL, Sulphuric acid, DPPH (2,2-Diphenyl-1-Picryl-Hydrazil) (Sigma Aldrich), paper disk (Sterile Susceptibility test disk SD067 Himedia Labs. Pvt. Ltd., Mumbai), Mueller-Hinton agar/ Potato Dextrose agar medium, Mueller-Hinton / Potato Dextrose broth medium, Alamer blue solution (0.01% in sterile D/W), Antibiotics (Streptomycin, Ethambutol, Ampicillin, Fluconazole) (Himedia Labs. Pvt. Ltd., Mumbai),
Plant samples: Acacia chundra (AC). Collected from S.R.T. M. University Nanded campus.
Test microorganisms
All Microbial cultures were procured from the Indian Institute of Microbial Technology Chandigarh India. Bacterial culture: Escherichia coli MCC 2412, Bacillus subtilis MCC 2048, Bacillus megaterium MCC 1684, Staphylococcus aureus MCC 2408, Klebsiella spp., Shigella spp., Pseudomonas aeruginosa MCC 2081, Staphylococcus epidermidis MCC 435, Propionibacterium acnes MCC 1951, Enterococcus faecalis MCC 2409, Mycobacterium tuberculosis MCC 300. Fungal culture: Candida albicans NIH 3147, Aspergillus niger MCC 281, Aspergillus flavus MCC 281, Rhizopus spp. MCC 262.
Phytochemical analysis
Preliminary phytochemical screening of the leaves, bark and flower solvent extracts of AC was performed as per standard procedure for identifying secondary metabolites in plants. The presence or absence of Alkaloids, saponins, tannins, steroids, flavonoids, phenolics and terpenoids have been examined by conducting tube test methods (Hidera et al., 2024).
Fourier transform infrared spectroscopy (FTIR)
Functional group and covalent bonding information were detected using FTIR spectroscopic analysis (Cary 630, Agilent Technologies, Virginia, USA). The built-in Resolution Pro software (2.5.5, Agilent) was used to analyze the data. (Antunes et al., 2024; Yassin et al., 2024).
UV- spectrum analysis
UV visible absorption studies were performed with Shimadzu spectrophotometer (model UV1900i, Shimadzu Corporation, Japan) using matched quartz cuvettes having path length of 1 cm. The phytoextracts was monitored by using UV-vis spectrum at wavelength 400-800 nm. As per shown in Figure 4.
Antimicrobial activity
Disk diffusion assay
The antimicrobial potential of the plant extract was assessed using the disk diffusion assay (More et al., 2018). The assay was performed for every bacterial species on freshly prepared Muller Hinton solidified agar medium. Here, we have followed the standard guidelines given by Clinical and Laboratory Standards Institute (CLSI). For disk diffusion assay Sterile paper disks (Sterile Susceptibility test disk SD067 Himedia Labs. Pvt. Ltd.,) were prepared, each loaded with 50 μL of the individual plant extract sample at a concentration of 1 mg/mL. These disks were placed on the surface of sterile Mueller-Hinton agar or Potato Dextrose agar medium, which had been previously inoculated with bacterial and fungal cultures Streptomycin (for E. coli, B. subtilis, B. megaterium, S. aureus, P. aeruginosa), Ethambutol for M. tuberculosis), Ampicillin (for Shigella, P. acne, S. epidemidis, E. faecalis) and fluconazole (for A. niger, C. albicans, A. flavous, Rhizopus spp.) were used as standard references at a concentration of 1 mg/mL. After 3 hr of refrigerated diffusion, the plates were transferred to an incubator set at 37ºC and 30ºC for 24 hr. Following incubation, the zones of inhibition around the paper disks were measured using a zone scale (Himedia Pvt. Ltd., Mumbai). This allowed us to assess the effectiveness of the test compounds against the bacterial and fungal strains.
Resazurin Microtiter Assay (REM) for MIC evaluation
The REMA plate assay was conducted as follows: While performing REM assay and calculating the MIC’s CLSI guidelines followed. 100 μL of Mueller-Hinton or Potato Dextrose broth medium was aseptically dispensed into each well of a sterile flat-bottom 96-well plate. Serial two-fold dilutions of the test sample were directly prepared in the plate. Subsequently, 100 μL of inoculum (0.5 McFarland standards, approximately equal to 1.5 × 108 CFU/mL) was added to each well. To prevent evaporation during incubation, sterile cold water was added to the perimeter wells. The plate was then covered with a sterile lid and incubated at 37ºC. After 24 hr of incubation, 30 μL of alamar blue solution (0.01% in sterile distilled water) from Himedia Labs Pvt. Ltd., was added to each well. For reference standard drugs were used against respective pathogen at concentration of 1 mg/mL. The plate was further incubated for 8 hr. A change in color from blue to pink indicated the growth of bacteria/fungi, and the Minimum Inhibitory Concentration (MIC) was determined as the lowest concentration of the compound that prevented this color change. The concentration range tested for the test compounds and standards was 0.97-500 μg/mL. for reference standard drugs were used as mentioned in disk diffusion methodology (Rakhe et al., 2024; Shaikh et al., 2024; More et al., 2020).
Antioxidant Activity
DPPH (2, 2-Diphenyl-1-Picrylhydrazyl radical scavenging assay)
The electron donation ability of each compound was assessed by monitoring the decolonization of a DPPH solution (More et al., 2020; Said et al., 2018) DPPH, a stable reagent, was used in this spectrophotometric assay. Briefly, equal volumes of the DPPH solution and the test compound were mixed to obtain a final volume of 3 mL. The mixture was then incubated for 20 min, followed by measuring the absorbance at 517 nm using a UV Spectrophotometer (Shimadzu Corp. Japan). Ascorbic acid (1 mM) served as the standard for comparison. The percent inhibition or radical scavenging activity was calculated using the formula:
OH (Hydroxyl radical assay)
The OH radical scavenging activity was evaluated using the Fenton reaction (Said et al., 2018; Baishya et al., 2024). Briefly, the typical reaction mixture comprised 60 µL of FeCl2 (1 mM), 90 µL of 1-10 phenanthroline (1 mM), and 2.4 mL of phosphate buffer (0.2 M, pH 7.8), 150 µL of H2O2 (0.17 M) and 1.5 mL of individual test compound (1 mg/mL). The reaction was initiated by introducing H2O2 and incubated for 5 min at room temperature. Following incubation, the absorbance was measured at 560 nm using UV Spectrophotometer (Shimadzu Corp. Japan). As a reference, ascorbic acid (1 mM) was employed. The determine the percent radical scavenging activity, the formula utilized was:
Hemolytic activity
The hemolytic activities using human RBCs for the selected screened compounds were determined following the literature method (Rakhe et al., 2024; Shaikh et al., 2024; Said et al., 2018; More et al., 2020). Human blood (5 mL) was initially collected in tubes containing 1 mg of EDTA (anti-coagulant). The erythrocytes were collected by centrifugation at 2000 rpm at 20ºC for 10 min. The collected pellet was washed thrice with PBS. Then, 10% (v/v) erythrocytes/PBS suspension was prepared using Phosphate buffered saline (PBS). From this, 1:10 dilution was prepared using PBS, which was used for the assay. 100 μL of erythrocytes were added to each well containing synthesized compounds 100 μL (500 μg/mL). 0.001 N Triton X 100 was used as a reference compound. The tubes were incubated for 1 hr at 37ºC and centrifuged repeatedly. From the supernatant, 150 μL solution was transferred to 96 well microplates, and the absorbance was measured at 540 nm using a plate reader. hemolysis was calculated using the following equation:
Statistical analysis
All the biological experiments were conducted in triplicate and the results are shown to be the mean values of three independent experiments. Antioxidants activities were shown to be n=3, ±SD.
RESULTS
Phytochemical analysis
In the present study, the phytochemical analysis of three extracts (aqueous, ethanolic, and chloroform) of AC leaves, bark, flower extracts showed the presence of all the phytoconstituents (alkaloids, saponins, tannins, steroids, flavonoids, phenolics and terpenoids) as shown in Table 1. The presence of these phytoconstituents in the three extracts (aqueous, ethanolic, and chloroform), therefore informed the utilization of the extracts for biological investigations. The results of phytochemical screening of different extracts are shown in (Table 1). In which ACLW, ACLE, ACBW, ACFW, and ACFE extracts contained alkaloids, saponins, and tannin. Steroids were absent in all extracts except for ACLE and ACFE. Flavonoids and phenolics were detected in ACLE, ACLC, ACBW, ACFE and ACFC the extracts. Terpenoids were present in ACLW, ACLE, ACFW and ACFC extracts. On the other hand, ACBC extracts did not contain alkaloids, saponins, tannin, steroids, Flavonoids, Phenolics, or Terpenoids.
| Alkaloids | Saponins | Tannin | Steroid | Flavonoids | Phenolics | Terpenoids | |
|---|---|---|---|---|---|---|---|
| Test | Wagner | Foam | FeCl3 | H2SO4 | Alkaline | FeCl3 | H2SO4 |
| ACLW | - | + | + | - | - | - | + |
| ACLE | + | + | + | - | + | + | + |
| ACLC | - | - | + | - | + | + | - |
| ACBW | - | + | + | - | + | + | - |
| ACBE | + | + | + | - | - | - | - |
| ACBC | - | - | - | - | - | - | - |
| ACFW | - | + | + | - | - | - | + |
| ACFE | + | + | + | - | + | + | + |
| ACFC | - | - | - | - | + | + | - |
Fourier Transform Infrared Spectroscopy (FTIR)
The ACBC, ACFC and ACLC shows good amount of phytoconstituents in the phytochemical analysis hence further it was assessed by FTIR spectra as shown in Figures 1-4. The FTIR spectra of ACBC showed total 1-8 peaks. As mentioned in Table 2 the peaks at 3319 cm represent N-H stretching and 2973 and 2882 -CH methyl stretch in alkane. The peaks at 1379 indicative of methyl group in alkanes and 1328 cm-1 correspond to the C6H4Cl2, 1087 represent C-O (C-O-C) in 4,4-diaminodiphenyl ether and 1045 cm-1 represents C-N bond in polystyrene, 879.62 corresponds to m2 symmetric deformation of the CO3 group in a compound. The ACFC FTIR spectra showed 1-8 peaks, among peak at 2976.24 indicate symmetrical and asymmetrical stretching of -CH2 functional group in fatty acid, peak at 2848.74 corresponds to the symmetric stretching of the -CH2 group, 1736.35 is the C=O bond in esters. For example, ethyl acetate has a strong band at 1736 cm-1 for the C=O bond. 1462.6 is associated with pyridine. Peak at 1254.6 is associated with the Si-CH2 bond in the GPTMS structure. Peak at 1060.29 is due to CH-O-CH stretching. Peak at 682.08 is characteristic of lead oxide in the FTIR spectrum of the pigment red lead. 652.99 is the compound Polysar Kynol 652 is available on Spectra Base (Marijana et al., 2022).
| Sample | Peak No. | X (cm-1) | Y (%T) | Description |
|---|---|---|---|---|
| ACBC | 1 | 3319.16 | 93.81 | NH- stretching |
| ACBC | 2 | 2973.5 | 77.93 | C-H stretching in alkane |
| ACBC | 3 | 2882.87 | 86.17 | C-H stretching in alkane |
| ACBC | 4 | 1379.87 | 84.66 | Frequency of 1379 cm-1 is a methyl rock in alkanes |
| ACBC | 5 | 1328.31 | 89.51 | Associated with C6H4Cl2 |
| ACBC | 6 | 1087.24 | 64.59 | Is a medium peak in the stretching vibration of C-O (C-O-C) in 4,4-diaminodiphenyl ether |
| ACBC | 7 | 1045.25 | 37.73 | Is associated with the C-N bond in polystyrene |
| ACBC | 8 | 879.62 | 66.54 | Corresponds to the m2 symmetric deformation of the CO3 group in a compound. |
| ACFC | 1 | 2916.24 | 83.4 | Symmetrical and asymmetrical stretching of -CH 2 functional group in fatty acid |
| ACFC | 2 | 2848.74 | 86.22 | Peak at 2848 cm-1 is due to the symmetric stretching of the -CH2 group. |
| ACFC | 3 | 1736.35 | 93.88 | C=O bond in esters. For example, ethyl acetate has a strong band at 1736 cm-1 for the C=O bond. |
| ACFC | 4 | 1462.6 | 91.37 | 1462 cm-1 is associated with pyridine |
| ACFC | 5 | 1254.6 | 92.89 | Frequency is associated with the Si-CH2 bond in the GPTMS structure. |
| ACFC | 6 | 1060.29 | 90.38 | Is due to CH-O-CH stretching. |
| ACFC | 7 | 682.08 | 100.43 | Is characteristic of lead oxide in the FTIR spectrum of the pigment red lead |
| ACFC | 8 | 652.99 | 100.54 | The compound Polysar Kynol 652 is available on SpectraBase. |
| ACLC | 1 | 3235.05 | 65.23 | Hydrogen bonded O-H stretching vibration |
| ACLC | 2 | 2950.98 | 99.66 | Tetrahedral carbon-hydrogen bonds |
| ACLC | 3 | 2076.14 | 95.51 | Is a positive peak in the spectrum of 2-diazomethylpyrazine. |
| ACLC | 4 | 1639.51 | 76.05 | Stretching vibration in dibenzalaceton |
| ACLC | 5 | 1180.47 | 93.74 | The C=S stretching frequency of thiofenchone is around 1180 cm-1 |
| ACLC | 6 | 1066.7 | 107.15 | Is the strongest peak in the FTIR spectrum of gaseous ethanol. |
| ACLC | 7 | 907.16 | 87.37 | Is associated with the Si-H band in hydrosilylation. |
The sample ACLC showed in total 1-7 peaks. Peak 3235.05 O-H stretching vibration, 2950.98 corresponds to tetrahedral carbon-hydrogen bonds. Peak at 2076.14 reflect a positive peak in the spectrum of 2-diazomethylpyrazine. Peak at 1639.51 indicate stretching vibration in dibenzalaceton. Peak at 1180.47 indicate. The C=S stretching frequency of thiofenchone is around 1180 cm-1. Peak at 1066.7 is the strongest peak in the FTIR spectrum of gaseous ethanol. Peak at 907.16 is associated with the Si-H band in hydrosilylation (Table 2).
Antimicrobial activities
Disk diffusion assay
The antimicrobial activity of AC leaves, bark and flower solvent extracts was determined by disc diffusion method and MIC was calculated by REM assay (Rakhe et al., 2024; Shaikh et al., 2024), with slight modification wherever needed. The crude extracts of AC (ethanolic, aqueous and chloroform with respective positive control streptomycin, ethambutol, fluconazole and ampicillin were used as positive control and double deionized water as negative control) were tested against 15 pathogenic microbial species where 11 bacterial and 4 fungal pathogenic species were used. The results are shown in Tables 3 and 4. The bacterial species Escherichia coli MCC 2412, Bacillus subtilis MCC 2048, Bacillus megaterium MCC 1684, Staphylococcus aureus MCC 2408, Klebsiella spp., Shigella spp., Pseudomonas aeruginosa MCC 2081, Propionibacterium acnes MCC 1951, Staphylococcus epidermidis MCC 435, Enterococcus faecalis MCC 2409, Mycobacterium tuberculosis MCC 300 and the fungal species Aspergillus niger, Candida albicans, Aspergillus flavous, Rhizopus spp., were used.
| Zone of inhibition in mm at 1 mg/mL | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample/Standard | EC | BM | BS | SA | KS | SS | PA | PAC | SE | EF | MTB |
| ACLW | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ |
| ACLE | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ |
| ACLC | ++ | + | + | + | ++ | ++ | ++ | ++ | + | + | + |
| ACBW | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | ++ |
| ACBE | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | NZ | +++ | +++ |
| ACBC | ++ | ++ | ++ | ++ | ++ | ++ | ++ | + | + | + | NZ |
| ACFW | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ | +++ |
| ACFE | +++ | +++ | ++ | +++ | ++ | +++ | ++ | +++ | ++ | +++ | ++ |
| ACFC | ++ | +++ | +++ | ++ | ++ | ++ | ++ | +++ | ++ | ++ | ++ |
| Streptomycin | +++ | +++ | +++ | +++ | NA | NA | +++ | NA | NA | NA | NA |
| Ethambutol | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | +++ |
| Fluconazole | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Ampicillin | NA | NA | NA | NA | +++ | +++ | NA | +++ | +++ | +++ | NA |
| Zone of inhibition in mm at 1 mg/mL | ||||
|---|---|---|---|---|
| Sample/Standard | C. albicans | A. niger | A. flavus | Rhizopus spp. |
| ACLW | +++ | +++ | +++ | +++ |
| ACLE | NZ | + | NZ | NZ |
| ACLC | + | + | + | + |
| ACBW | +++ | +++ | +++ | ++ |
| ACBE | +++ | +++ | +++ | NZ |
| ACBC | NZ | NZ | NZ | NZ |
| ACFW | + | NZ | + | + |
| ACFE | ++ | +++ | +++ | +++ |
| ACFC | ++ | ++ | ++ | NZ |
| Fluconazole | +++ | +++ | +++ | +++ |
The assessment of antibacterial activity of the plant extracts was documented in Table 3, revealing varying levels of efficacy against diverse bacterial strains. Notably, the AC leaf extracts (ACLW, ACLE, ACLC) exhibited substantial antimicrobial activity, with ACLW and ACLE displaying the highest zone of inhibition compared to ACLC. Were standard antibiotics (Streptomycin, Ampicillin, Ethambutol) used for comparison Similarly, the bark extracts (ACBW, ACBE, ACBC) and flower extracts (ACFW, ACFE, ACFC) demonstrated potent inhibitory effects against the tested microorganisms, with ACBW, ACBE, ACFW, and ACFE exhibiting the most significant zone of inhibition in contrast to the chloroform extracts of bark and flower, which showed minimal inhibitory zones (Table 3). Zone of inhibition of solvent extract of various plant parts of AC against human bacterial pathogens.
Results are the average mean of three parallel experiments.
EC=Escherichia coli MCC 2412, BS=Bacillus subtilis MCC 2048, BM=Bacillus megaterium MCC 1684, SA=Staphylococcus aureus MCC 2408, KS=Klebsiella spp., SS=Shigella spp., PA=Pseudomonas aeruginosa MCC 2081, PAC=Propionibacterium acnes MCC 1951, SE=Staphylococcus epidermidis MCC 435, EF=Enterococcus faecalis MCC 2409, MTB=Mycobacterium tuberculosis MCC 300.
Overall, the results from the Disk Diffusion assay suggest that the water and ethanol solvent extracts of AC possess promising potential as natural antimicrobial agents effective against a wide range of human bacterial pathogens as shown in Table 3.
Results are the average mean of three parallel experiments.
The antifungal efficacy of solvent extracts from various parts of the AC plant was evaluated against human fungal pathogens, with results summarized in Table 4. The extracts exhibited varying degrees of inhibition against Candida albicans, Aspergillus niger, Aspergillus flavus, and Rhizopus spp., ACLW, ACBW, ACBE, ACFW, and ACFE extracts demonstrated significant antifungal activity, with maximum zones of inhibition against the tested pathogens. ACFC extract showed moderate inhibition, while ACLC extract exhibited minimal activity. The antifungal potency of the extracts was compared to that of the standard antifungal agent, fluconazole, to assess their relative efficacy.
Overall, the results of the Disk Diffusion assay indicate that the water and ethanol solvents extract of AC have the potential to be used as natural antimicrobial agents against a variety of human fungal pathogens (Candida albicans NIH 3147, Rhizopus spp. MCC 262, Aspergillus niger MCC 281, Aspergillus flavus MCC 281).
REM assay
The Minimum Inhibitory Concentration (MIC) values of the plant extract (ACLW, ACLE, ACLC ACBW, ACBE, ACBC, ACFW, ACFE, ACFC) recorded in Table 5. Against various bacterial pathogens were determined to assess their potency as antimicrobial agents. Table 5 and Figure 5 illustrates the MIC values for specific bacterial strains, highlighting the efficacy of these plant extracts in inhibiting bacterial growth. Notably, ACLE exhibited a MIC of 3.25±0.01 μg/mL against Escherichia coli MCC 2412, Bacillus subtilis MCC 2048, and Bacillus megaterium MCC 1684, while displaying a slightly higher MIC of 6.5±0.02 μg/mL for other bacterial species tested, excluding Klebsiella spp. This indicates the strong antimicrobial activity of ACLE against these common bacterial pathogens. Similarly, ACBE demonstrated a MIC of 3.25±0.01 μg/mL for Escherichia coli MCC 2412, Bacillus subtilis MCC 2048, Pseudomonas aeruginosa MCC 2081, and Propionibacterium acnes MCC 1951. The MIC for Enterococcus faecalis MCC 2409 and Mycobacterium tuberculosis MCC 300 was slightly higher at 6.5±0.02 μg/mL. These results suggest that ACBE is effective against a range of bacterial species, including both Gram-positive and Gram-negative pathogens. Furthermore, ACFE exhibited a MIC of 3.25±0.01 μg/mL against Escherichia coli MCC 2412, Bacillus subtilis MCC 2048, Propionibacterium acnes MCC 1951, and Enterococcus faecalis MCC 2409. This highlights the potent antimicrobial activity of ACFE against these specific bacterial strains.
| MIC of plant samples in µg/mL | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample/Standard | EC | BM | BS | SA | KS | SS | PA | PAC | SE | EF | MTB |
| ACLW | 52.08±0.18 | 52.08±0.18 | 41.66±0.18 | 208.33±0.72 | 26.01±0.09 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 51.75±0.18 | 208.33±0.72 |
| ACLE | 3.25±0.01 | 3.25±0.01 | 3.25±0.01 | 6.5±0.02 | 52.08±0.18 | 6.5±0.02 | 6.5±0.02 | 6.5±0.02 | 3.25±0.01 | 6.5±0.02 | 6.5±0.02 |
| ACLC | 41.66±0.18 | 52.08±0.18 | 208.33±0.72 | 52.08±0.18 | 208.33±0.72 | 52.08±0.18 | 52.08±0.18 | 208.33±0.72 | 208.33±0.72 | 52.08±0.18 | 208.33±0.72 |
| ACBW | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 104.16667 | 104.16±0.36 | 104.16±0.36 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 |
| ACBE | 3.25±0.01 | 3.25±0.01 | 26.03±0.09 | 104.16±0.36 | 52.08±0.18 | 13±0.04 | 3.25±0.01 | 3.25±0.01 | 13±0.04 | 6.5±0.02 | 6.5±0.02 |
| ACBC | 13±0.04 | 208.33±0.72 | 208.33±0.72 | 3.25±0.01 | 3.25±0.01 | 13±0.04 | 3.25±0.01 | 3.25±0.01 | 13.1±0.04 | 3.25±0.01 | 11.7±0.06 |
| ACFW | 208.33±0.72 | 104.16±0.36 | 104.16±0.36 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 11.7±0.06 |
| ACFE | 3.25±0.01 | 3.25±0.01 | 208.33±0.72 | 104.16±0.36 | 208.33±0.72 | 13±0.04 | 208.33±0.72 | 3.25±0.01 | 208.33±0.72 | 3.25±0.01 | 52.08±0.18 |
| ACFC | 52.16±0.17 | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 104.16±0.36 | 13±0.04 | 3.25±0.01 | 52.08±0.18 |
| Streptomycin | 1.6±0.05 | 3.25±0.01 | 1.6±0.05 | 1.6±0.05 | NA | NA | 1.95 | NA | NA | NA | NA |
| Ethambutol | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 3.25±0.01 |
| Ampicillin | NA | NA | NA | NA | 1.6±0.05 | 3.25±0.01 | NA | 1.6±0.05 | 3.25±0.01 | 1.6±0.05 | NA |
Overall, the MIC values of ACLE, ACBE, and ACFE indicate their potential as effective natural antimicrobial agents with broad-spectrum activity against a variety of bacterial pathogens, making them promising candidates for further research and development in combating infectious diseases.
The antifungal activity of plant extract demonstrated by their Minimum Inhibitory Concentration (MIC) values, is significant and promising. presents the MIC values for specific fungal species, highlighting the efficacy of these plant extracts in inhibiting fungal growth recorded in Table 6. Specifically, ACLE exhibited a MIC of 6.5±0.02 μg/mL against Candida albicans NIH 3147, Aspergillus flavus MCC 281, and Rhizopus spp. MCC 262. These results indicate that ACLE has notable antifungal activity against a range of fungal pathogens. On the other hand, ACFC demonstrated a MIC of 3.25±0.01 μg/mL against Candida albicans NIH 3147 and Rhizopus spp. MCC 262. as mentioned in Table 6. This extract showed comparable antifungal activity to the standard antifungal drug fluconazole, suggesting its potential as an effective natural alternative for combating fungal infections. The results suggest that both ACLE and ACFC have promising antifungal properties, with ACFC showing particularly potent activity against Candida albicans and Rhizopus spp. These findings support further research into the potential use of these plant extracts as natural antifungal agents for the treatment of fungal infections (Li et al., 2024).
| Sample/Standard | C. albicans | A. niger | A. flavus | Rhizopus spp. |
|---|---|---|---|---|
| ACLW | 52.08±0.18 | 104.16±0.36 | 104.16±0.36 | 416.66±0.144 |
| ACLE | 6.5±0.02 | 52.08±0.18 | 6.5±0.02 | 6.5±0.02 |
| ACLC | 3.25±0.01 | 208.33±0.72 | 208.33±0.72 | 416.66±0.144 |
| ACBW | 208.33±0.72 | 208.33±0.72 | 3.25±0.01 | 416.66±0.144 |
| ACBE | 13.1±0.04 | 13±0.04 | 6.5±0.02 | 13±0.04 |
| ACBC | 208.33±0.72 | 208.33±0.72 | 208.33±0.72 | 416.66±0.144 |
| ACFW | 52.08±0.18 | 104.16±0.36 | 104.16±0.36 | 416.66±0.144 |
| ACFE | 208.33±0.72 | 52.08±0.18 | 208.33±0.72 | 3.25±0.01 |
| ACFC | 3.25±0.01 | 26.03±0.09 | 13±0.04 | 3.25±0.01 |
| Fluconazole | 1.6±0.05 | 1.6±0.05 | 1.6±0.05 | 1.6±0.05 |
Antioxidant activities
The antioxidant activity of solvent extracts from various plant parts of AC was evaluated using the DPPH scavenging assay, with the results summarized in Figure 6. Revealing distinct levels of efficacy among the tested extracts. Notably, ACLC, ACLE, and ACFC demonstrated outstanding antioxidant potential by exhibiting more than 50% scavenging activity against the DPPH free radical. In contrast, ACLW, ACBW, ACFW, ACFE, and ACBE showcased significant antioxidant capacity with over 30% scavenging activity, while the remaining extracts displayed moderate scavenging activity.
Moreover, in the hydroxyl radical assay, ACFW, ACLE, and ACLC showcased remarkable antioxidant activity with more than 30% scavenging activity. Conversely, ACBW, ACBC, ACFE, and ACFC demonstrated moderate scavenging activity in this assay. These results underscore the diverse and potent antioxidant capabilities of the solvent extracts derived from different plant parts of AC. The findings highlight the potential of specific extracts as valuable natural antioxidants for a wide range of applications, emphasizing the importance of exploring these natural sources for their beneficial properties.
Cytotoxicity studies
The cytotoxic effect of plant samples on normal mammalian cells was performed by this assay in which healthy human’s fresh RBCs were used. In this study, ACFW, ACLC and ACBC possesses near about 1% cytotoxicity towards human RBC’s. All other test samples showed negligible cytotoxicity <1% as compared with the standard Triton X 100 which showed 8.2% cytotoxicity as shown in (Figure 7).
DISCUSSION
The study evaluated the antimicrobial, antioxidant, and cytotoxic potential of Acacia chundra (AC) extracts, revealing promising outcomes. Phytochemical screening indicated the presence of alkaloids, saponins, tannins, flavonoids, phenolics, and terpenoids in most extracts, except ACBC, suggesting these bioactive compounds contribute to observed activities. Ethanolic extracts (ACLE, ACBE, ACFE) exhibited potent antimicrobial activity, with Minimum Inhibitory Concentrations (MIC) of 3.25±0.01 µg/mL against Escherichia coli, Bacillus megaterium, Bacillus subtilis, Pseudomonas aeruginosa, Propionibacterium acnes, and Enterococcus faecalis, comparable to standard antibiotics. ACLE and ACFW showed moderate to good antifungal potential, while ACBC lacked activity, indicating part-specific and solvent-dependent efficacy. FTIR and UV spectral analysis confirmed the presence of diverse phytochemicals, supporting the extracts' broad-spectrum antimicrobial activity. Antioxidant assays (DPPH and OH radical scavenging) revealed significant activity in ACLE, ACLC, and ACFC, attributed to phenolics and flavonoids. Notably, all extracts showed negligible cytotoxicity (<1% hemolysis) towards human RBCs, indicating safety.
CONCLUSION
Acacia chundra extracts, particularly ACLE and ACFE, demonstrate significant antimicrobial and antioxidant activities with minimal cytotoxicity, validating its traditional medicinal use. The broad-spectrum efficacy against bacterial and fungal pathogens suggests potential for treating oral, dermal, pulmonary, and genital infections. Further research is needed to isolate, characterize, and evaluate in vivo efficacy and safety of bioactive compounds.
